Lepu Biopharma Shareholders Approve Key Resolutions

Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.

Lepu Biopharma Co., Ltd. successfully held its 2023 Annual General Meeting (AGM) on June 19, 2024, where all proposed resolutions were passed by shareholders’ polls. Notably, the re-appointment of PricewaterhouseCoopers as the company’s auditor for 2024 and the authorization for the Board to issue additional shares were among the key resolutions approved. The AGM’s high approval rates signal robust shareholder support for the company’s direction and governance.

For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.